Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 35

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 35
---
 If we fail to adequately integrate digital capabilities into our organization and business model, we could lose patients and market share. This could have an adverse impact on our business, prospects, and results of operations. Because AI is an emerging technology, it is possible that our use of AI technologies may not have the intended effects or benefits, such as increasing efficiency. In addition, the use of AI technologies presents certain risks, including the use of personal data as described above (see “— Failure to comply with data ethics and privacy regulations could adversely affect our business and reputation" above). The success of digital initiatives will also depend on our ability to shift our culture to a data-driven culture and to transform the architecture of our business process designs to integrate AI. This calls for management of data as an asset and the definition of a robust life-cycle management process for data that is applied consistently across Sanofi. Misuse of such technologies could negatively affect our reputation, disrupt our operations, or otherwise have a material adverse impact on our financial results and could also subject us to legal and reputational risks. We may fail to accelerate our operational efficiency and perform our transformation program As part of the presentation of the next chapter of our Play to Win strategy in October 2023, we announced our intent to improve our operating efficiencies to fund growth. We also announced savings of a total of up to €2 billion from 2024 to the end of 2025, most of which will be reallocated to fund innovation and growth drivers. We also announced our intent to separate Opella, with an anticipated closing date of the transaction at the earliest in the second quarter 2025, subject to obtaining regulatory approvals from the competent authorities. (See also “— Completion of the separation of Opella is subject to conditions that may not be satisfied and we may fail to realize any or all of the anticipated benefits of the separation and/or face unintended adverse impacts on our business”). To deploy our strategy, we must also disrupt our normal course of business and transform our operations. Nevertheless, we may not succeed in federating employees behind the transformation program, which may hamper our ability to execute such organizational changes. Besides, there is no guarantee that we will be able to fully deliver these operating efficiencies or separate the Opella business within the targeted timeline, or at all, or generate the expected benefits.

| 14 | SANOFIFORM 20-F2024 |

| PART I                  |
| ITEM 3. Key Information |

Unsuccessful management of sustainability (environmental, social and governance) matters could